Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

4-(4-ForMyl-3-Methoxyphenoxy)butanoic Acid

4-(4-ForMyl-3-Methoxyphenoxy)butanoic Acid Structure
  • ₹0
  • Product name: 4-(4-ForMyl-3-Methoxyphenoxy)butanoic Acid
  • CAS: 309964-23-6
  • MF: C12H14O5
  • MW: 238.24
  • EINECS:218-624-9
  • MDL Number:MFCD01317807
  • Synonyms:FMPBA;FMPB LINKER;4-(4'-CARBOXYBUTYLOXY)-2-METHOXYBENZALDEHYDE;4-(4'-FORMYL-3'-METHOXY)PHENOXY BUTYRIC ACID;4-(4-FORMYL-3-METHOXY-PHENOXY)-BUTYRIC ACID;4-(3-METHOXY-4-FORMYL)PHENOXYBUTYRIC ACID;4-FORMYL-MPBA;4-FORMYL-3-METHOXYPHENOXY BUTANOIC ACID
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Boiling point :461.5±35.0 °C(Predicted)
Density :1.232±0.06 g/cm3(Predicted)
storage temp. :0-6°C
pka :4.59±0.10(Predicted)
CAS DataBase Reference :309964-23-6(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

4-(4-ForMyl-3-Methoxyphenoxy)butanoic Acid can be used in the preparation of amino(benzoyl)2-furylthiazoles and related compounds as adenosine A2A receptor antagonists via either a multistep procedure or a solid phase combinatorial preparation.